Lexicon Pharmaceuticals, Inc. (LXRX)
USD 0.45
(2.46%)
USD 0.45
(2.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 99.5 Million USD | 84.26% |
| 2022 | 54 Million USD | 4438.07% |
| 2021 | 1.19 Million USD | 94.76% |
| 2020 | 611 Thousand USD | -99.74% |
| 2019 | 235.27 Million USD | -3.53% |
| 2018 | 243.88 Million USD | 5.32% |
| 2017 | 231.57 Million USD | 171.91% |
| 2016 | 85.16 Million USD | -17.95% |
| 2015 | 103.79 Million USD | 18.62% |
| 2014 | 87.5 Million USD | 333.88% |
| 2013 | 20.16 Million USD | -7.82% |
| 2012 | 21.87 Million USD | -6.71% |
| 2011 | 23.45 Million USD | -17.67% |
| 2010 | 28.48 Million USD | -57.47% |
| 2009 | 66.96 Million USD | 126.77% |
| 2008 | 29.52 Million USD | -3.16% |
| 2007 | 30.49 Million USD | -2.8% |
| 2006 | 31.37 Million USD | -2.54% |
| 2005 | 32.18 Million USD | -2.28% |
| 2004 | 32.94 Million USD | -41.54% |
| 2003 | 56.34 Million USD | 1308.6% |
| 2002 | 4 Million USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 1.83 Million USD | -49.06% |
| 1999 | 3.6 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 99.49 Million USD | -0.38% |
| 2024 Q1 | 99.87 Million USD | 0.37% |
| 2023 FY | 99.5 Million USD | 84.26% |
| 2023 Q4 | 99.5 Million USD | -4.97% |
| 2023 Q1 | 54.29 Million USD | 0.55% |
| 2023 Q3 | 104.7 Million USD | 0.44% |
| 2023 Q2 | 104.25 Million USD | 92.0% |
| 2022 Q3 | 29.22 Million USD | 18.63% |
| 2022 Q2 | 24.63 Million USD | 0.24% |
| 2022 Q1 | 24.57 Million USD | 1965.13% |
| 2022 FY | 54 Million USD | 4438.07% |
| 2022 Q4 | 54 Million USD | 84.8% |
| 2021 FY | 1.19 Million USD | 94.76% |
| 2021 Q3 | 1.48 Million USD | -8.75% |
| 2021 Q4 | 1.19 Million USD | -19.65% |
| 2021 Q1 | 1.71 Million USD | 181.01% |
| 2021 Q2 | 1.62 Million USD | -5.47% |
| 2020 Q3 | 11.62 Million USD | -95.05% |
| 2020 Q2 | 234.8 Million USD | 0.14% |
| 2020 Q1 | 234.48 Million USD | -0.33% |
| 2020 FY | 611 Thousand USD | -99.74% |
| 2020 Q4 | 611 Thousand USD | -94.75% |
| 2019 Q4 | 235.27 Million USD | 0.61% |
| 2019 FY | 235.27 Million USD | -3.53% |
| 2019 Q2 | 243.95 Million USD | 0.02% |
| 2019 Q1 | 243.91 Million USD | 0.01% |
| 2019 Q3 | 233.83 Million USD | -4.15% |
| 2018 Q2 | 232.19 Million USD | 0.14% |
| 2018 FY | 243.88 Million USD | 5.32% |
| 2018 Q4 | 243.88 Million USD | 0.02% |
| 2018 Q1 | 231.87 Million USD | 0.13% |
| 2018 Q3 | 243.83 Million USD | 5.01% |
| 2017 Q2 | 85.38 Million USD | 0.13% |
| 2017 Q4 | 231.57 Million USD | 170.81% |
| 2017 FY | 231.57 Million USD | 171.91% |
| 2017 Q1 | 85.26 Million USD | 0.12% |
| 2017 Q3 | 85.51 Million USD | 0.15% |
| 2016 Q3 | 85.03 Million USD | 0.15% |
| 2016 FY | 85.16 Million USD | -17.95% |
| 2016 Q4 | 85.16 Million USD | 0.15% |
| 2016 Q1 | 100.55 Million USD | -3.12% |
| 2016 Q2 | 84.9 Million USD | -15.56% |
| 2015 Q2 | 87.5 Million USD | 0.0% |
| 2015 FY | 103.79 Million USD | 18.62% |
| 2015 Q3 | 87.5 Million USD | 0.0% |
| 2015 Q1 | 87.5 Million USD | 0.0% |
| 2015 Q4 | 103.79 Million USD | 18.62% |
| 2014 Q4 | 87.5 Million USD | 11246.5% |
| 2014 FY | 87.5 Million USD | 333.88% |
| 2014 Q2 | 19.25 Million USD | -2.31% |
| 2014 Q3 | -785 Thousand USD | -104.08% |
| 2014 Q1 | 19.71 Million USD | -2.26% |
| 2013 Q4 | 20.16 Million USD | -2.14% |
| 2013 FY | 20.16 Million USD | -7.82% |
| 2013 Q3 | 20.6 Million USD | -9.12% |
| 2013 Q2 | 22.67 Million USD | 5.69% |
| 2013 Q1 | 21.45 Million USD | -1.92% |
| 2012 Q3 | 22.28 Million USD | -1.74% |
| 2012 Q4 | 21.87 Million USD | -1.83% |
| 2012 Q2 | 22.67 Million USD | -1.67% |
| 2012 Q1 | 23.06 Million USD | -1.65% |
| 2012 FY | 21.87 Million USD | -6.71% |
| 2011 Q1 | 27.04 Million USD | -1.1% |
| 2011 FY | 23.45 Million USD | -17.67% |
| 2011 Q4 | 23.45 Million USD | -1.57% |
| 2011 Q3 | 23.82 Million USD | -1.5% |
| 2011 Q2 | 24.18 Million USD | -10.56% |
| 2010 Q3 | 27.64 Million USD | -1.01% |
| 2010 Q4 | 27.34 Million USD | -1.07% |
| 2010 FY | 28.48 Million USD | -57.47% |
| 2010 Q1 | 28.19 Million USD | -0.99% |
| 2010 Q2 | 27.92 Million USD | -0.98% |
| 2009 Q4 | 28.48 Million USD | -0.95% |
| 2009 Q1 | 43.93 Million USD | 48.8% |
| 2009 Q2 | 66.97 Million USD | 52.42% |
| 2009 Q3 | 28.75 Million USD | -57.07% |
| 2009 FY | 66.96 Million USD | 126.77% |
| 2008 Q1 | 30.25 Million USD | -0.79% |
| 2008 FY | 29.52 Million USD | -3.16% |
| 2008 Q4 | 29.52 Million USD | -0.84% |
| 2008 Q3 | 29.77 Million USD | -0.8% |
| 2008 Q2 | 30.01 Million USD | -0.77% |
| 2007 Q1 | 31.15 Million USD | -0.69% |
| 2007 FY | 30.49 Million USD | -2.8% |
| 2007 Q4 | 30.49 Million USD | -0.75% |
| 2007 Q3 | 30.72 Million USD | -0.71% |
| 2007 Q2 | 30.94 Million USD | -0.69% |
| 2006 FY | 31.37 Million USD | -2.54% |
| 2006 Q2 | 31.78 Million USD | -0.62% |
| 2006 Q3 | 31.58 Million USD | -0.63% |
| 2006 Q4 | 31.37 Million USD | -0.67% |
| 2006 Q1 | 31.98 Million USD | -0.64% |
| 2005 FY | 32.18 Million USD | -2.28% |
| 2005 Q2 | 32.56 Million USD | -0.55% |
| 2005 Q3 | 32.38 Million USD | -0.56% |
| 2005 Q4 | 32.18 Million USD | -0.6% |
| 2005 Q1 | 32.74 Million USD | -0.58% |
| 2004 FY | 32.94 Million USD | -41.54% |
| 2004 Q4 | 32.94 Million USD | -11.26% |
| 2004 Q3 | 37.12 Million USD | -0.45% |
| 2004 Q2 | 37.28 Million USD | -33.82% |
| 2004 Q1 | 56.34 Million USD | 0.0% |
| 2003 Q2 | 4 Million USD | 0.0% |
| 2003 FY | 56.34 Million USD | 1308.6% |
| 2003 Q1 | 4 Million USD | 0.0% |
| 2003 Q3 | 4 Million USD | 0.0% |
| 2003 Q4 | 56.34 Million USD | 1308.6% |
| 2002 FY | 4 Million USD | 0.0% |
| 2002 Q4 | 4 Million USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | -100.0% |
| 2001 FY | - USD | -100.0% |
| 2001 Q3 | 58.9 Thousand USD | 0.0% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q1 | 1.57 Million USD | -13.9% |
| 2000 Q1 | 3.3 Million USD | 0.0% |
| 2000 Q3 | 2.2 Million USD | -8.71% |
| 2000 FY | 1.83 Million USD | -49.06% |
| 2000 Q2 | 2.42 Million USD | -26.84% |
| 2000 Q4 | 1.83 Million USD | -17.0% |
| 1999 FY | 3.6 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -39.715% |
| Alkermes plc | 287.73 Million USD | 65.416% |
| Agenus Inc. | 137.32 Million USD | 27.538% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 95.753% |
| Aptorum Group Limited | 3.05 Million USD | -3153.49% |
| Ardelyx, Inc. | 51.54 Million USD | -93.043% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | 4.875% |
| Bicycle Therapeutics plc | 40.08 Million USD | -148.273% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | 1.084% |
| ChromaDex Corporation | 2.57 Million USD | -3764.388% |
| Chimerix, Inc. | 125 Thousand USD | -79506.4% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -2972.533% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -284.082% |
| CRISPR Therapeutics AG | 223 Million USD | 55.379% |
| Precision BioSciences, Inc. | 7.72 Million USD | -1188.463% |
| Dyadic International, Inc. | 88.87 Thousand USD | -111870.294% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -452209.091% |
| Fortress Biotech, Inc. | 60.85 Million USD | -63.514% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -161712.15% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -2517.943% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -110312.321% |
| Incyte Corporation | 29.16 Million USD | -241.225% |
| IO Biotech, Inc. | 1.83 Million USD | -5310.984% |
| Jaguar Health, Inc. | 30.99 Million USD | -221.066% |
| Novavax, Inc. | 168.01 Million USD | 40.775% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -332.174% |
| Opthea Limited | 200.53 Million USD | 50.379% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -1629.07% |
| ContextLogic Inc. | 6 Million USD | -1558.467% |
| MiMedx Group, Inc. | 48.09 Million USD | -106.882% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -395.089% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -259773.077% |
| NextCure, Inc. | 5.94 Million USD | -1572.684% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -68526.207% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -350.038% |
| PDS Biotechnology Corporation | 19.5 Million USD | -410.136% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | 13.831% |
| Pharming Group N.V. | 166.1 Million USD | 40.093% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -1501.61% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -196.906% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -8151.078% |
| Acelyrin, Inc. | 1.19 Million USD | -8234.003% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -21532.174% |
| Summit Therapeutics Inc. | 103.29 Million USD | 3.662% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -2540.17% |
| Senti Biosciences, Inc. | 33.53 Million USD | -196.702% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -1984.81% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -187.962% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -64.964% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -6238.089% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -291.702% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | 4.629% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -13493.989% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -789.179% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 28.051% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -640.442% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -563.387% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 47.883% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -88.97% |
| Fortress Biotech, Inc. | 60.85 Million USD | -63.514% |
| Precigen, Inc. | 5.89 Million USD | -1588.007% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -136.992% |
| AlloVir, Inc. | 16.64 Million USD | -497.717% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -51.327% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -2.206% |
| ImmuCell Corporation | 10.54 Million USD | -844.054% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -8745.156% |
| Onconetix, Inc. | 118.85 Thousand USD | -83620.774% |
| PureTech Health plc | 18.25 Million USD | -445.249% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -100413.131% |
| Elevation Oncology, Inc. | 30.13 Million USD | -230.185% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -283.254% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -132.094% |
| Innoviva, Inc. | 446.23 Million USD | 77.7% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -11845.738% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -148766.016% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 51.921% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -39.766% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -3021.33% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -9486.513% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -345.705% |
| Aptose Biosciences Inc. | 621 Thousand USD | -15923.833% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -9743.175% |
| Century Therapeutics, Inc. | 46.65 Million USD | -113.271% |
| Kura Oncology, Inc. | 9.33 Million USD | -966.309% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -272.689% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -72007.246% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -960.288% |
| Autolus Therapeutics plc | 47.91 Million USD | -107.68% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -1928.292% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -1369.186% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | 23.842% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -1127.736% |
| IGM Biosciences, Inc. | 34.67 Million USD | -186.998% |
| INmune Bio, Inc. | 397 Thousand USD | -24964.987% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 42.73% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2354.406% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -67616.01% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -99.928% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -82.349% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -117.775% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 78.979% |
| Verastem, Inc. | 40.08 Million USD | -148.236% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -2160.518% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -889.735% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -1416.659% |
| Histogen Inc. | 4.38 Million USD | -2169.799% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -11182.086% |
| Organovo Holdings, Inc. | 888 Thousand USD | -11105.856% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -231.693% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -2272.628% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -426.637% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -31.45% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -106778.33% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -284.097% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -37168.914% |
| Amarin Corporation plc | 8.73 Million USD | -1038.926% |
| Mesoblast Limited | 100.48 Million USD | 0.97% |
| Turnstone Biologics Corp. | 1.18 Million USD | -8269.05% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -27.039% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -91191.743% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -21.338% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 47.612% |
| Better Therapeutics, Inc. | 10.34 Million USD | -861.616% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -330.305% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -6.96% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -7601.858% |
| Gritstone bio, Inc. | 40.14 Million USD | -147.878% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -5385.557% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 35.213% |
| Insmed Incorporated | 1.19 Billion USD | 91.661% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -1467.055% |
| OmniAb, Inc. | 22.07 Million USD | -350.772% |
| Alector, Inc. | 30.45 Million USD | -226.727% |
| Seres Therapeutics, Inc. | 101.54 Million USD | 2.005% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -1136.585% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 76.674% |
| Aura Biosciences, Inc. | 16.87 Million USD | -489.852% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -74.901% |
| Immunic, Inc. | 639 Thousand USD | -15472.457% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -233.707% |
| Veracyte, Inc. | 7.52 Million USD | -1222.365% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 84.569% |
| FibroGen, Inc. | 89.69 Million USD | -10.938% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2194.397% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -75939.828% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 98.052% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -268840.541% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -4925.657% |
| TG Therapeutics, Inc. | 100.11 Million USD | 0.609% |
| Galecto, Inc. | 66 Thousand USD | -150669.697% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -73067.647% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 93.904% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -1554.331% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -1743.765% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -5385.557% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -363.972% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -172.214% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -19147.195% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -119.975% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -225.466% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -122.106% |
| Vaxxinity, Inc. | 13.26 Million USD | -650.324% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 87.734% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -22059.522% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -1032.188% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 96.318% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -31389.873% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -2132.122% |
| Ainos, Inc. | 5.92 Million USD | -1580.437% |
| Pluri Inc. | 29.05 Million USD | -242.505% |
| Prothena Corporation plc | 10.72 Million USD | -828.16% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -401.274% |
| Celularity Inc. | 26.17 Million USD | -280.135% |
| Rallybio Corporation | 173 Thousand USD | -57419.075% |
| Cue Biopharma, Inc. | 4.2 Million USD | -2268.11% |
| MeiraGTx Holdings plc | 72.11 Million USD | -37.978% |
| Omeros Corporation | 329.7 Million USD | 69.819% |
| Humacyte, Inc. | 38.6 Million USD | -157.793% |
| Immunocore Holdings plc | 82.64 Million USD | -20.406% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -6069.126% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -2681.884% |
| Blueprint Medicines Corporation | 610.96 Million USD | 83.713% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -6724.966% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -4.537% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -104.396% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -9.469% |
| Pulmatrix, Inc. | 8.32 Million USD | -1095.004% |
| Elicio Therapeutics, Inc. | 6 Million USD | -1556.534% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -668.698% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -2.854% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -21117.058% |
| Cytokinetics, Incorporated | 607.37 Million USD | 83.617% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -1044.823% |
| Nutriband Inc. | 79.82 Thousand USD | -124556.127% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -2119.179% |
| Vor Biopharma Inc. | 31.83 Million USD | -212.623% |
| Roivant Sciences Ltd. | 477.85 Million USD | 79.176% |
| Evogene Ltd. | 10.65 Million USD | -834.084% |
| ProKidney Corp. | 3.61 Million USD | -2656.454% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -13010.408% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -377883.742% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 94.267% |
| CorMedix Inc. | 517.01 Thousand USD | -19146.711% |
| BioLineRx Ltd. | 6.62 Million USD | -1401.328% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -170.123% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -38.705% |
| Atai Life Sciences N.V. | 15.21 Million USD | -554.184% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -11712.595% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -38922.745% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -130.61% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -24131.238% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -7168.663% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -14906.507% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 44.119% |
| Biomea Fusion, Inc. | 7.83 Million USD | -1170.856% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 64.988% |
| Mereo BioPharma Group plc | 5.3 Million USD | -1777.509% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -4528.279% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -16823.129% |
| Absci Corporation | 4.66 Million USD | -2035.365% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -763.635% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -338.458% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -894.583% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -764.911% |
| Allakos Inc. | 38.21 Million USD | -160.39% |
| Imunon, Inc. | 1.13 Million USD | -8634.189% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -1053.181% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -11802.871% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -994980.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -12.634% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -2013.145% |
| XOMA Corporation | 118.51 Million USD | 16.04% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -888.261% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -168.368% |
| aTyr Pharma, Inc. | 13.76 Million USD | -622.801% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -1159.754% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -298.606% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -392.492% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -663286.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -35669.798% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -588.405% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 93.363% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -72974.692% |
| UroGen Pharma Ltd. | 98.55 Million USD | -0.971% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 33.267% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -421.886% |
| Entera Bio Ltd. | 256 Thousand USD | -38770.313% |
| GH Research PLC | 631 Thousand USD | -15669.889% |
| Lisata Therapeutics, Inc. | 137.00 USD | -72633476.642% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -15399.688% |
| Xencor, Inc. | 14.64 Million USD | -579.607% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -66127.845% |
| Replimune Group, Inc. | 71.99 Million USD | -38.225% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -66238.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -1320.325% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -72974.692% |
| Portage Biotech Inc. | 7000.00 USD | -1421442.857% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -14906.507% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -6863.471% |
| OncoCyte Corporation | 2.2 Million USD | -4414.882% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -148630.289% |
| Purple Biotech Ltd. | 163 Thousand USD | -60947.853% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -3825.365% |
| scPharmaceuticals Inc. | 38.81 Million USD | -156.391% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -294.185% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -136212.329% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -5270.103% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -277.668% |
| Curis, Inc. | 1.48 Million USD | -6582.874% |
| Daré Bioscience, Inc. | 3.91 Million USD | -2442.571% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -14161.984% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -1658366.667% |
| BeiGene, Ltd. | 197.61 Million USD | 49.646% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -10816.95% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -23.497% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -91.771% |
| bluebird bio, Inc. | 224.41 Million USD | 55.66% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 83.222% |
| DBV Technologies S.A. | 4.52 Million USD | -2098.586% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -7325.97% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -921.433% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -2541.572% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 73.624% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -132.078% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -5695.457% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -10622.845% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -469.691% |
| MacroGenics, Inc. | 30.19 Million USD | -229.54% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -462.097% |
| Prime Medicine, Inc. | 4.35 Million USD | -2183.865% |
| Aditxt, Inc. | 1.04 Million USD | -9452.059% |
| Adagene Inc. | 13.54 Million USD | -634.917% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -624.379% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 80.816% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -482.156% |
| SciSparc Ltd. | 24 Thousand USD | -414516.667% |
| Vericel Corporation | 81.85 Million USD | -21.565% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -21.326% |
| Generation Bio Co. | 89.77 Million USD | -10.843% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -348.537% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 50.69% |
| Invivyd, Inc. | 722 Thousand USD | -13682.271% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -105.163% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -3403360.648% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -2501.516% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -432543.478% |
| 2seventy bio, Inc. | 244.01 Million USD | 59.22% |
| ADMA Biologics, Inc. | 130.59 Million USD | 23.804% |
| Clene Inc. | 7.15 Million USD | -1291.331% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -2847.286% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 59.814% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -8937.965% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -37755.173% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 48.34% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -250.343% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -932.348% |
| Vir Biotechnology, Inc. | 111.67 Million USD | 10.893% |
| Evaxion Biotech A/S | 8.48 Million USD | -1072.234% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -32.81% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -53.763% |
| Trevena, Inc. | 35.23 Million USD | -182.428% |
| Surrozen, Inc. | 882 Thousand USD | -11182.086% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -1500.837% |
| Cingulate Inc. | 135.09 Thousand USD | -73555.616% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -322.737% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -108.176% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -55182.222% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -292.088% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -470.672% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -10531.197% |
| Statera Biopharma, Inc. | 11.43 Million USD | -770.499% |
| ImmunityBio, Inc. | 836.95 Million USD | 88.111% |
| Korro Bio, Inc. | 31.21 Million USD | -218.772% |
| Kineta, Inc. | 150 Thousand USD | -66238.667% |
| BioVie Inc. | 349.89 Thousand USD | -28339.47% |
| Codexis, Inc. | 12.24 Million USD | -712.775% |
| Celularity Inc. | 26.17 Million USD | -280.135% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -109.248% |
| Celcuity Inc. | 37.03 Million USD | -168.683% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -56328.025% |
| Cibus, Inc. | 17.67 Million USD | -463.019% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -2844.895% |
| Kodiak Sciences Inc. | 100 Million USD | 0.492% |
| Annexon, Inc. | 29.19 Million USD | -240.898% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -53.973% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -8768.806% |
| Avalo Therapeutics, Inc. | 2 Million USD | -4875.4% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 92.894% |
| Eyenovia, Inc. | 8.95 Million USD | -1010.924% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -51.553% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -1122.157% |
| Arcellx, Inc. | 50.84 Million USD | -95.724% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -6724.966% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -368.538% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -9332.038% |
| Moolec Science SA | 99.04 Thousand USD | -100366.45% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -260.262% |
| Geron Corporation | 35.05 Million USD | -183.895% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -16737.225% |
| Royalty Pharma plc | 6.13 Billion USD | 98.378% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -5960.171% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -313390.013% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -329.877% |
| Humacyte, Inc. | 38.6 Million USD | -157.793% |
| Structure Therapeutics Inc. | 4.01 Million USD | -2379.641% |
| 89bio, Inc. | 24.79 Million USD | -301.323% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -700.29% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -5232.69% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -9542.248% |
| Notable Labs, Ltd. | 1.52 Million USD | -6420.839% |
| Liquidia Corporation | 2.36 Million USD | -4109.306% |
| Mustang Bio, Inc. | 1.97 Million USD | -4930.738% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -624.379% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -1331.152% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -31290.536% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -99.507% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -936.11% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -151846.128% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -73067.647% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -1488.57% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -76444.615% |
| PepGen Inc. | 17.1 Million USD | -481.918% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -20893.249% |
| United Therapeutics Corporation | 300 Million USD | 66.831% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -315.638% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -2290.38% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -17115.917% |
| XOMA Corporation | 118.51 Million USD | 16.04% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -268840.541% |
| Bionomics Limited | 117.62 Million USD | 15.404% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -10565.38% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -1673.761% |
| uniQure N.V. | 130.06 Million USD | 23.494% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -69.838% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -14405.539% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2194.397% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -7084.693% |
| Altimmune, Inc. | 175 Thousand USD | -56761.714% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 74.344% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -1673.761% |
| Compugen Ltd. | 719 Thousand USD | -13739.777% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -1864.232% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -17.684% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -902.095% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -1459.931% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -8.859% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -902.095% |
| Instil Bio, Inc. | 81.42 Million USD | -22.205% |
| argenx SE | 15.35 Million USD | -548.092% |
| Immunome, Inc. | 1.34 Million USD | -7325.97% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -18464.925% |
| Verona Pharma plc | 48.37 Million USD | -105.706% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -979.731% |
| Shattuck Labs, Inc. | 3.4 Million USD | -2821.55% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -116968.235% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -59130.952% |
| Moolec Science SA | 99.04 Thousand USD | -100366.45% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -801.989% |
| AnaptysBio, Inc. | 16.03 Million USD | -520.49% |
| Design Therapeutics, Inc. | 2.33 Million USD | -4163.41% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -367481.545% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -1558.467% |
| Achilles Therapeutics plc | 1.07 Million USD | -9147.955% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -979.731% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -499037.239% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -494.346% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -124556.127% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -1333608.618% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -765346.154% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 70.945% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -306.421% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -3880.336% |
| Palisade Bio, Inc. | 90 Thousand USD | -110464.444% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -51192.784% |
| Beam Therapeutics Inc. | 159.91 Million USD | 37.773% |
| Neurogene Inc. | 13.37 Million USD | -644.096% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 67.526% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -278.89% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -166240.142% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -9850.8% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -145.65% |
| Athira Pharma, Inc. | 1.21 Million USD | -8076.5% |
| Vaccinex, Inc. | 26 Thousand USD | -382623.077% |
| HCW Biologics Inc. | 6.3 Million USD | -1478.41% |
| XOMA Corporation | 118.51 Million USD | 16.04% |
| Nektar Therapeutics | 112.62 Million USD | 11.647% |
| Arvinas, Inc. | 800 Thousand USD | -12338.5% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -588.405% |
| Merus N.V. | 10.48 Million USD | -848.78% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -568.512% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -640.993% |
| Rezolute, Inc. | 1.66 Million USD | -5894.458% |
| Clene Inc. | 7.15 Million USD | -1291.331% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -135565.594% |
| BeyondSpring Inc. | 3.36 Million USD | -2858.026% |
| Synlogic, Inc. | 12.49 Million USD | -696.638% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -204.716% |
| Krystal Biotech, Inc. | 6.62 Million USD | -1403.142% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 41.781% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -1559.573% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -209961.008% |
| MannKind Corporation | 252.15 Million USD | 60.536% |
| Ikena Oncology, Inc. | 7.18 Million USD | -1285.905% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -49904.02% |
| Gossamer Bio, Inc. | 197.4 Million USD | 49.592% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -19036.154% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 64.629% |
| Mural Oncology plc | 8.91 Million USD | -1016.687% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -127.52% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -6829.526% |
| Champions Oncology, Inc. | 6.09 Million USD | -1533.153% |
| REGENXBIO Inc. | 82.22 Million USD | -21.024% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -20043.198% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -2144.204% |
| Vaxart, Inc. | 2.62 Million USD | -3693.671% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -36533.521% |
| Cellectis S.A. | 36.24 Million USD | -174.573% |
| Longeveron Inc. | 1.44 Million USD | -6772.099% |
| Repare Therapeutics Inc. | 1.01 Million USD | -9752.277% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 91.214% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -122.27% |
| Revolution Medicines, Inc. | 80.57 Million USD | -23.497% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -3001.87% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -56119.209% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -80800.813% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 86.269% |
| Denali Therapeutics Inc. | 44.98 Million USD | -121.222% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -695.793% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -73555.616% |
| Passage Bio, Inc. | 22.92 Million USD | -334.135% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -1547.756% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -15279.907% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -393.469% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -20207.755% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -24321.718% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -8276.094% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -21253.648% |
| OmniAb, Inc. | 22.07 Million USD | -350.772% |
| Anew Medical, Inc. | 1.54 Million USD | -6361.558% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -236.631% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -1001.605% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -220.064% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2354.406% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -93.006% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -1462.871% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -604.282% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -14707.738% |
| Alumis Inc. Common Stock | 30.86 Million USD | -222.45% |
| Equillium, Inc. | 384 Thousand USD | -25813.542% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -1515.652% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 34.122% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -103.58% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -82615.167% |
| Dominari Holdings Inc. | 3.02 Million USD | -3186.262% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -503151.909% |
| vTv Therapeutics Inc. | 169 Thousand USD | -58780.473% |
| Bio-Techne Corporation | 319 Million USD | 68.806% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -74.612% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 44.274% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -545.862% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -703.586% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -1970.064% |
| Nkarta, Inc. | 82.27 Million USD | -20.953% |
| BioCardia, Inc. | 982 Thousand USD | -10033.198% |
| Iterum Therapeutics plc | 18.95 Million USD | -424.942% |